Literature DB >> 9125002

In vivo effect of alpha 1-acid glycoprotein on experimentally enhanced capillary permeability in guinea-pig skin.

E M Muchitsch1, W Teschner, Y Linnau, L Pichler.   

Abstract

Anesthetized guinea-pigs were intravenously injected with Evans blue. After intracutaneous injection of agonists (lys-plasminogen, histamine, platelet-activating factor, thrombin, bradykinin), the resulting wheals appeared blue in a dose-dependent manner, due to an enhanced capillary permeability, alpha 1-Acid glycoprotein, given i.v. in different doses (3.125-50 mg/kg) and at different times (30-180 min) before Evans blue administration, antagonized the effects of all agonists listed above. This was shown by a parallel shift of the agonist dose-response curves to the right. The effect was time-dependent (tmax: mainly 120 min) and dose-dependent. alpha 1-Acid glycoprotein antagonized the agonists in the following order: lys-plasminogen > histamine = platelet-activating factor > thrombin > bradykinin. As all agonist mentioned are suggested to play a major role in the shock-related increase in vascular permeability, a putatively beneficial role of alpha1-acid glycoprotein in shock is discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9125002

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  5 in total

Review 1.  Orosomucoid, an acute response protein with multiple modulating activities.

Authors:  Zhumin Luo; Hong Lei; Yang Sun; Xia Liu; Ding-Feng Su
Journal:  J Physiol Biochem       Date:  2015-02-25       Impact factor: 4.158

2.  Orosomucoid 2 inhibits tumor metastasis and is upregulated by CCAAT/enhancer binding protein β in hepatocellular carcinomas.

Authors:  Tao Fang; Meiling Cui; Ji Sun; Chao Ge; Fangyu Zhao; Lin Zhang; Hua Tian; Lixing Zhang; Taoyang Chen; Guoping Jiang; Haiyang Xie; Ying Cui; Ming Yao; Hong Li; Jinjun Li
Journal:  Oncotarget       Date:  2015-06-30

3.  Vaccinia virus-specific molecular signature in atopic dermatitis skin.

Authors:  Dmitry N Grigoryev; Michael D Howell; Tonya N Watkins; Yu-Chi Chen; Chris Cheadle; Mark Boguniewicz; Kathleen C Barnes; Donald Y M Leung
Journal:  J Allergy Clin Immunol       Date:  2010-01       Impact factor: 10.793

4.  The acute phase reactant orosomucoid-1 is a bimodal regulator of angiogenesis with time- and context-dependent inhibitory and stimulatory properties.

Authors:  Giovanni Ligresti; Alfred C Aplin; Bruce E Dunn; Ann Morishita; Roberto F Nicosia
Journal:  PLoS One       Date:  2012-08-14       Impact factor: 3.240

5.  Types of acute phase reactants and their importance in vaccination.

Authors:  Rafaat H Khalil; Nabil Al-Humadi
Journal:  Biomed Rep       Date:  2020-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.